首页 | 本学科首页   官方微博 | 高级检索  
     

结直肠癌PRL-3蛋白表达与临床关系的Meta分析
引用本文:王 旖1,杨 贤1,王宏坤2,郑绘霞2,梁建芳1. 结直肠癌PRL-3蛋白表达与临床关系的Meta分析[J]. 现代肿瘤医学, 2018, 0(12): 1870-1876. DOI: 10.3969/j.issn.1672-4992.2018.12.017
作者姓名:王 旖1  杨 贤1  王宏坤2  郑绘霞2  梁建芳1
作者单位:1.山西医科大学第一临床医学院,山西 太原 030001;2.山西医科大学第一医院病理科,山西 太原 030001
摘    要:目的:研究促肝再生磷酸酶蛋白(PRL-3)在结直肠癌患者癌组织中的表达与临床病理特征的相关性。方法:检索知网、万方、和pubmed、Web of science、EMBASE等数据库以“PRL-3,结直肠癌”为主要检索词收集从2000年至2017年1月1日,国内外公开发表的关于PRL-3和结直肠癌临床病理特征关系的相关文献,对文献筛选和评价,符合标准的文献用RevMan5.3分析软件进行Meta分析。结果:最终纳入16篇文献,共包括1 489例病例,835例正常对照。PRL-3蛋白在结直肠癌组的表达与年龄、性别差异无统计学意义(P>0.05)。PRL-3蛋白在正常大肠黏膜组织的表达低于结直肠癌组(I2=12%,P<0.000 01,OR=4.01);PRL-3蛋白在高分化的结直肠癌组的表达低于中、低分化组(OR=1.45,P=0.03,I2=39%);PRL-3蛋白在未超过浆膜层组的表达低于侵及或超过浆膜层组(OR=2.36,P=0.01,I2=61%);PRL-3蛋白在无淋巴结转移组的表达低于有转移组(OR=3.74,P<0.000 01,I2=54%),采用随机效应模型进行Meta分析;PRL-3蛋白在不伴有肝转移组的表达低于有肝转移组(OR=2.88,P<0.000 1,I2=36%);PRL-3蛋白在Ⅰ+Ⅱ期组的表达低于Ⅲ+Ⅳ期组(OR=7.97,P<0.000 01,I2=28%)。结论:PRL-3参与了结直肠癌发生、发展、转移过程,是预后不良的指征。

关 键 词:PRL-3  结直肠癌  Meta分析

PRL-3 expression and its clinicopathological significance in colorectal cancer:Meta-analysis
Wang Yi1,Yang Xian1,Wang Hongkun2,Zheng Huixia2,Liang Jianfang1. PRL-3 expression and its clinicopathological significance in colorectal cancer:Meta-analysis[J]. Journal of Modern Oncology, 2018, 0(12): 1870-1876. DOI: 10.3969/j.issn.1672-4992.2018.12.017
Authors:Wang Yi1  Yang Xian1  Wang Hongkun2  Zheng Huixia2  Liang Jianfang1
Affiliation:1.The First Clinical Medical College,Shanxi Medical University,Shanxi Taiyuan 030001,China;2.Department of Pathology,the First Hospital of Shanxi Medical University,Shanxi Taiyuan 030001,China.
Abstract:Objective:To investigate the correlation of the expression phosphatase of regenerating liver-3 and clinicopathological features.Methods:Systematic computerized searches of CNKI,Wanfang,Cqvip,CBMdisc,PubMed,Web of science,EMBASE,Wiley Online Library databases meeting specified search criteria were peformed from year 2000 to Jan.1 2017,with "PRL-3,colorectal cancer"as key words,followed by a further screening according to inclusive and exclusive criteria,and the data meeting the selected standard were carried out by Revman5.3.Results:Sixteen reports were selected based on the standard,including 1 489 patients with colorectal cancer and 835 cases with normal controls.Expression of PRL-3 in colorectal cancer and age,gender,the difference was no significant(P>0.05).The level of PRL-3 in colorectal cancer higher in normal colonic mucosa (I2=12%,P<0.000 01,OR=4.01).The level of PRL-3 in moderately and poorly differentiated cancer were higher than well differentiation(OR=1.45,P=0.03,I2=39%).The level of PRL-3 in colorectal cancer with the invased subserosa higher muscularis and serosal layer(OR=2.36,P=0.01,I2=61%).The expression of PRL-3 in colorectal cancer with lymph node metastasis was higher than without metastasis (OR=3.74,P<0.000 01,I2=54%),so random effects model to merge was used.The expression of PRL-3 in Colorectal Cancer with liver metastasis was higher than without metastasis (OR=2.88,P<0.000 1,I2=36%).The level of PRL-3 in Ⅲ+Ⅳ of TNM stage was higher than ⅠandⅡstage (OR=7.97,P<0.000 01,I2=28%).Conclusion:PRL-3 expression in the incidence,development and metastasis of colorectal cancer is positively associated with the malignancy of the tumor and may be a sign of poor prognosis.
Keywords:PRL-3   colorectal cancer   Meta-analysis
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号